ADVFN - Advanced Financial Network.
HOME» NYSE » B » BEC Stock Price » BEC Stock News

Beckman Coulter Share News

 Beckman Coulter, Inc. Stock Price
BEC Stock Price
 Beckman Coulter, Inc. Stock Chart
BEC Stock Chart
 Beckman Coulter, Inc. Stock News
BEC Stock News
 Beckman Coulter, Inc. Company Information
BEC Company Information
 Beckman Coulter, Inc. Stock Trades
BEC Stock Trades

Beckman Deal Moves Danaher Deeper Into Technology Sector

By Bob Tita Of DOW JONES NEWSWIRES Danaher Corp.'s (DHR) acquisition of Beckman Coulter Inc. (BEC) moves the industrial conglomerate deeper into the medical-technology sector. Beckman makes diagnostic equipment used in hospitals and clinics. Danaher has been transitioning from industries that require large bases of fixed assets in plants, machinery and materials in favor of technology companies where growth is largely driven by research and product development. Danaher announced last month that it will sell its portfolio of aerospace and defense businesses and off-loaded its hand tools business last year to a joint venture with Cooper Industries. Danaher's business lines include testing and measurement instruments, life sciences technology, dental appliances, water treatment and product identification equipment. The addition of almost $4 billion a year in revenue from Beckman would raise Danaher's medical, dental and life sciences businesses to 47% of the company's total annual sales. Chief Executive Lawrence Culp Jr. said Monday he's not concerned about Danaher's becoming too concentrated in healthcare. Culp doesn't anticipate any additional large health sector deals this year. "We're at a little bit of a high-water mark here I suspect, but it's temporary," Culp said during a conference call with analysts on Monday. "Over time, when you think about Danaher as a $20 to $25 billion [a year] company, you should really think about that [health-care] exposure being 40%, give or take." In 2010, Danaher's net income rose 4% from 2009 to $1.8 billion, or $2.64 a share. Revenue rose 18% to $13.2 billion. Danaher relies on acquisitions to fortify slow-growing base revenue. The company has a reputation for being able to expand margins of the companies it buys through aggressive cost reductions and efficiency improvements. Analysts say it is unclear whether the company's business strategy will be as successful with technology companies as it has been with asset-heavy manufacturing companies. Beckman's gross margin of 45% is below Danaher's gross margin of 50%. "The general rule of thumb is that they've been buying businesses that are accretive to Danaher's gross margin," said Richard Eastman, an analyst with Robert W. Baid & Co. Beckman "has more margin opportunity than some of the others have offered." Danaher's stock closed up 2.2%, or $1.05, at $49.03 a share. The stock set a new 52-week high at $50.29 during Monday's regular trading session. Meanwhile, Beckman Coulter closed up 10%, or $7.48, to $82.65. -By Bob Tita, Dow Jones Newswires; 312-750-4129; robert.tita@dowjones.com

Stock News for Beckman Coulter (BEC)
DateTimeHeadline
06/28/201113:48:41CORRECT:Danaher In Market With Offering To Help Fund Acquisition
06/17/201104:07:36EU Clears US Technology Firm Danaher To Buy Beckman Coulter
04/18/201111:54:16Beckman Coulter Delays FDA Filings For Key Heart Test To 3Q
02/25/201112:38:49PerkinElmer Isn't For Sale, CEO Says; Shares Slide
02/24/201111:44:18PerkinElmer, After Beckman-Bid Loss, Is Mulling Deals -Bloomberg
02/07/201116:48:21Beckman Deal Moves Danaher Deeper Into Technology Sector
02/07/201108:14:50Danaher Agrees To Acquire Beckman Coulter For $5.87 Billion
01/28/201114:25:16KKR Said To Drop Out Of Beckman Coulter Bid Group -Bloomberg
07/06/201015:19:05FDA Warns Beckman Coulter On Marketing Of "AccuTnI" Heart Test
05/14/201009:52:56Beckman Coulter Expects First Half 2011 Troponin Filing
12/17/200917:11:22Beckman Coulter Targets Mid-Teens Earnings Growth In 2010

Beckman Coulter and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad